Compound Evaluation in Scn2aQ54 Mice

Project: Research project

Project Details

Description

To evaluate in vivo anti-seizure activity of three test compounds in the Scn2aQ54 mouse model of epilepsy caused by a mutation of Scn2a that results in elevated persistent sodium current (Kearney et al, 2001).
StatusFinished
Effective start/end date12/9/186/12/20

Funding

  • Praxis Precision Medicines, Inc. (Prot #IS00004487)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.